Proteomic analysis of an imatinib-resistant K562 cell line highlights opposing roles of heat shock cognate 70 and heat shock 70 proteins in resistance

Proteomics

Volumn 8, Issue 12, 2008, Pages 2394-2406

  Pocaly, Marion ^a   Lagarde, Valérie ^a   Etienne, Gabriel ^a   Dupouy, Maryse ^a   Lapaillerie, Delphine ^a   Claverol, Stéphane ^a   Vilain, Sébastien ^a   Bonneu, Marc ^a   Turcq, Béatrice ^a   Mahon, François Xavier ^a   Pasquet, Jean Max ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Bcr Abl; Chronic myeloid leukemia; Drug resistance; Heat shock protein; Imatinib

Indexed keywords

CHAPERONE; DNA; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN 70; IMATINIB; SMALL INTERFERING RNA;

ARTICLE; CELL STRAIN K 562; DRUG SENSITIVITY; ENZYME METABOLISM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 48249094972     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200701035     Document Type: Article

References (51)

1. Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T. et al., Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer. Res. 1996, 56, 100-104.
2. Buchdunger, E., Cioffi, C. L., Law, N., Stover, D. et al., Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Then 2000, 295, 139-145.
3. Daley, G. Q., Dodging the magic bullet: Understanding imatinib resistance. Cancer Biol. Ther. 2003, 2, 109-110.
4. Donato, N. J., Wu, J. Y., Stapley, J., Lin, H. et al., Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer. Res. 2004, 64, 672-677.
5. Mahon, F. X., Deininger, M. W., Schultheis, B., Chabrol, J. et al., Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance. Blood 2000, 96, 1070-1079.
6. Pasquet, J. M., Pocaly, M., Lagarde, V., Turcq, B. et al., The proteome analysis of an imatinib-resistant cell line identifies changes in molecular chaperones such as heat shock proteins (Hsp): A possible new mechanism of imatinib-resistance. Blood 2004, 104, 1981.
7. Pocaly, M., Lagarde, V., Etienne, G., Ribeil, J. A. et al., Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia. Leukemia 2007, 21, 93-101.
8. Vilain, S., Cosette, P., Hubert, M., Lange, C. et al., Proteomic analysis of agar gel-entrapped Pseudomonas aeruginosa. Proteomics 2004, 4, 1996-2004.
9. Mahon, F. X., Belloc, F., Lagarde, V., Chollet, C. et al., MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models. Blood 2003, 101, 2368-2373.
10. Yamamoto, A., Mizukami, Y., Sakurai, H., Identification of a novel class of target genes and a novel type of binding sequence of heat shock transcription factor in Saccharomyces cerevisiae. J. Biol. Chem. 2005, 280, 11911-11919.
11. Pocaly, M., Lagarde, V., Etienne, G., Ribeil, J. A. et al., Heat shock protein 70 over expression is associated to imatinib resistance in chronic myelogenous leukemia. Blood 2005, 106, 2005.
12. Weisberg, E., Manley, P., Mestan, J., Cowan-Jacob, S. et al., AMN107 (nilotinib): A novel and selective inhibitor of BCR-ABL. Br. J. Cancer 2006, 94, 1765-1769.
13. O'hare, T., Eide, C. A., Deininger, M. W., Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia. Blood 2007, 110, 2242-2249.
14. Ray, A., Cowan-Jacob, S. W., Manley, P. W., Mestan, J. et al., Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study. Blood 2007, 109, 5011-5015.
15. Samali, A., Cotter, T. G., Heat shock proteins increase resistance to apoptosis. Exp. Cell Res. 1996, 223, 163-170.
16. Ciocca, D. R., Calderwood, S. K., Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10, 86-103.
17. Penuelas, S., Noe, V., Morales, R., Ciudad, C. J., Sensitization of human erythroleukemia K562 cells resistant to methotrexate by inhibiting IMPDH. Med. Sci. Monit. 2005, 11, 76-12.
18. Calderwood, S. K., Khaleque, M. A., Sawyer, D. B., Ciocca, D. R., Heat shock proteins in cancer: Chaperones of tumorigenesis. Trends Biochem. Sci. 2006, 31, 164-172.
19. Donato, N. J., Wu, J. Y., Stapley, J., Gallick, G. et al., BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood 2003, 101, 690-698.
20. Watanabe, T., Tsuge, H., Oh-Hara, T., Naito, M. et al., Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo. Acta Oncol. 1995, 34, 235-241.
21. Ferrari, G., Pastorelli, R., Buchi, F., Spinelli, E. et al., Comparative proteomic analysis of chronic myelogenous leukemia cells: Inside the mechanism of imatinib resistance. J. Proteome Res. 2007, 6, 367-375.
22. Carpenter, B., Mackay, C., Alnabulsi, A., Mackay, M. et al., The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim. Biophys. Acta 2006, 1765, 85-100.
23. Kamada, S., Miwa, T., A protein binding to CArG box motifs and to single-stranded DNA functions as a transcriptional repressor. Gene 1992, 119, 229-236.
24. Rushlow, W. J., Rajakumar, N., Flumerfelt, B. A., Naus, C. C., Characterization of CArG-binding protein A initially identified by differential display. Neuroscience 1999, 94, 637-649.
25. Gao, C., Guo, H., Wei, J., Mi, Z. et al., S-nitrosylation of heterogeneous nuclear ribonucleoprotein A/B regulates osteopontin transcription in endotoxin-stimulated murine macrophages. J. Biol. Chem. 2004, 279, 11236-11243.
26. Lai, M. C., Kuo, H. W., Chang, W. C., Tarn, W. Y., A novel splicing regulator shares a nuclear import pathway with SR proteins. EMBO J. 2003, 22, 1359-1369.
27. Grosset, C., Chen, C. Y., Xu, N., Sonenberg, N. et al., A mechanism for translationally coupled mRNA turnover: Interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex. Cell 2000, 103, 29-40.
28. Blanc, V., Navaratnam, N., Henderson, J. O., Anant, S. et al., Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing. J. Biol. Chem. 2001, 276, 10272-10283.
29. Perrotti, D., Calabretta, B., Translational regulation by the p210 BCR/ABL oncoprotein. Oncogene 2004, 23, 3222-3229.
30. Balabanov, S., Gontarewicz, A., Ziegler, P., Hartmann, U. et al., Hypusination of eukaryotic initiation factor 5A (EIF-5A): A novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach. Blood 2007, 109, 1701-1711.
31. Nowicki, M. O., Pawlowski, P., Fischer, T., Hess, G. et al., Chronic myelogenous leukemia molecular signature. Oncogene 2003, 22, 3952-3963.
32. Jackson, R. C., Weber, G., Morris, H. P., IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 1975, 256, 331-333.
33. Penuelas, S., Noe, V., Ciudad, C. J., Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells. FEBS J. 2005, 272, 696-710.
34. Gu, J. J., Santiago, L., Mitchell, B. S., Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl. Blood 2005, 105, 3270-3277.
35. Dulhunty, A., Gage, P., Curtis, S., Chelvanayagam, G. et al., The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J. Biol. Chem. 2001, 276, 3319-3323.
36. Schmitz, H. D., Reversible nuclear translocation of glyceraldehyde-3- phosphate dehydrogenase upon serum depletion. Eur. J. Cell Biol. 2001, 80, 419-427.
37. Noma, T., Song, S., Yoon, Y.-S., Tanaka, S. et al., cDNA cloning and tissue-specific expression of the gene encoding human adenylate kinase isozyme 2. Biochim. Biophys. Acta 1998, 1395, 34-39.
38. Juhnke, H., Krems, B., Kotter, P., Entian, K. D., Mutants that show increased sensitivity to hydrogen peroxide reveal an important role for the pentose phosphate pathway in protection of yeast against oxidative stress. Mol. Gen. Genet. 1996, 252, 456-464.
39. Tsai, M.-Y., Wang, S., Heidinger, J. M., Shumaker, D. K. et al., A mitotic lamin B matrix induced by RanGTP required for spindle assembly. Science 2006, 311, 1887-1893.
40. Lin, C., Park, T., Chen, Z., Leavitt, J., Human plastin genes. Comparative gene structure, chromosome location, and differential expression in normal and neoplastic cells. J. Biol. Chem. 1993, 268, 2781-2792.
41. Foran, E., Mcwilliam, P., Kelleher, D., Croke, D. T. et al., The leukocyte protein L-plastin induces proliferation, invasion and loss of E-cadherin expression in colon cancer cells. Int. J. Cancer 2006, 118, 2098-2104.
42. Ngan, C. Y., Yamamoto, H., Seshimo, I., Tsujino, T. et al., Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br. J. Cancer 2007, 96, 986-992.
43. Pratt, W. B., Gehring, U., Toft, D. O., Molecular chaperoning of steroid hormone receptors. Experientia 1996, 77, 79-95.
44. Christians, E. S., Yan, L. J., Benjamin, I. J., Heat shock factor 1 and heat shock proteins: Critical partners in protection against acute cell injury. Crit. Care Med. 2002, 30, S43-S50.
45. Garrido, C., Gurbuxani, S., Ravagnan, L., Kroemer, G., Heat shock proteins: Endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Commun. 2001, 286, 433-442.
46. Nunes, S. L., Calderwood, S. K., Heat shock factor-1 and the heat shock cognate 70 protein associate in high molecular weight complexes in the cytoplasm of NIH-3T3 cells. Biochem. Biophys. Res. Commun. 1995, 213, 1-6.
47. Ahn, S. G., Kim, S. A., Yoon, J. H., Vacratsis, P., Heat-shock cognate 70 is required for the activation of heat-shock factor 1 in mammalian cells. Biochem. J. 2005, 392, 145-152.
48. Matsui, H., Asou, H., Inaba, T., Cytokines direct the regulation of Bim mRNA stability by heat-shock cognate protein 70. Mol. Cell. 2007, 25, 99-112.
49. Lim, S. O., Park, S. G., Yoo, J. H., Park, Y. M. et al., Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World J. Gastroenterol. 2005, 11, 2072-2079.
50. Thomas, X., Campos, L., Le, Q. H., Guyotat, D., Heat shock proteins and acute leukemias. Hematology 2005, 10, 225-235.
51. Hubbard, M. J., Mchugh, N. J., Human ERp29: Isolation, primary structural characterisation and two-dimensional gel mapping. Electrophoresis 2000, 21, 3785-3796.